Citadel Advisors’s Immunovant IMVT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.59M Sell
144,398
-10,109
-7% -$262K ﹤0.01% 4918
2025
Q4
$3.93M Sell
154,507
-592,046
-79% -$13.2M ﹤0.01% 4690
2025
Q3
$12M Buy
746,553
+396,161
+113% +$6.41M 0.01% 2990
2025
Q2
$5.61M Buy
350,392
+22,567
+7% +$341K ﹤0.01% 3909
2025
Q1
$5.6M Sell
327,825
-116,188
-26% -$2.43M 0.01% 3694
2024
Q4
$11M Buy
444,013
+104,092
+31% +$2.95M 0.01% 2864
2024
Q3
$9.69M Sell
339,921
-3,591
-1% -$106K 0.01% 2942
2024
Q2
$9.07M Buy
343,512
+115,013
+50% +$3.27M 0.01% 2893
2024
Q1
$7.38M Sell
228,499
-582,940
-72% -$21.3M 0.01% 3368
2023
Q4
$34.2M Sell
811,439
-33,937
-4% -$1.25M 0.03% 1495
2023
Q3
$32.5M Buy
845,376
+539,527
+176% +$12.2M 0.04% 1435
2023
Q2
$5.8M Sell
305,849
-860,027
-74% -$16M 0.01% 3419
2023
Q1
$18.1M Buy
1,165,876
+193,154
+20% +$3.35M 0.02% 2027
2022
Q4
$17.3M Buy
972,722
+901,589
+1,267% +$11.4M 0.02% 2121
2022
Q3
$397K Sell
71,133
-38,872
-35% -$190K ﹤0.01% 8955
2022
Q2
$429K Sell
110,005
-114,586
-51% -$495K ﹤0.01% 8995
2022
Q1
$1.24M Sell
224,591
-23,170
-9% -$144K ﹤0.01% 7216
2021
Q4
$2.11M Buy
247,761
+79,018
+47% +$652K ﹤0.01% 6106
2021
Q3
$1.47M Sell
168,743
-6,669
-4% -$60.2K ﹤0.01% 7138
2021
Q2
$1.85M Sell
175,412
-384,929
-69% -$5.37M ﹤0.01% 6791
2021
Q1
$8.99M Sell
560,341
-208,693
-27% -$5.5M 0.01% 3140
2020
Q4
$35.5M Buy
769,034
+67,959
+10% +$3.14M 0.04% 1237
2020
Q3
$24.7M Buy
701,075
+487,423
+228% +$14.7M 0.03% 1394
2020
Q2
$5.2M Buy
213,652
+195,896
+1,103% +$4.2M 0.01% 3027
2020
Q1
$276K Buy
+17,756
New +$267K ﹤0.01% 7482

Other funds holding IMVT